Varun Monga

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar et al. · Cancer Cell · 2017 · 438 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations

Priscilla K. Brastianos, Erin Twohy, Elizabeth R. Gerstner et al. · Journal of Clinical Oncology · 2022 · 105 citations · Full text

Medicine, Cancer Biology, Oncology +14

Improved survival for extremity soft tissue sarcoma treated in high‐volume facilities

Tyler Abarca, Yubo Gao, Varun Monga et al. · Journal of Surgical Oncology · 2018 · 86 citations · Full text

Medicine, Oncology, Surgery +14

First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Bryan G. Allen, Kellie L. Bodeker, Mark C. Smith et al. · Clinical Cancer Research · 2019 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

Yvonne M. Mowery, Karla V. Ballman, Angela Hong et al. · The Lancet · 2024 · 78 citations · Full text

Medicine, Oncology, Surgery +14